Atea showcased its Phase III HCV programme at JPM for bemnifosbuvir/ruzasvir, positioning the regimen for test-and-treat adoption in ~1,800 patients. C-BEYOND data are expected mid-2026, with C-FORWARD results by year-end...
91% of clinical research associates concerned with burnout and turnover, third-party data query resolution can cost sponsors millions.
The pharmaceutical industry continues to be a hotbed of innovation, with activity driven by the evolution of new treatment paradigms,...
Understand the themes driving your sector, keep up with key innovation areas and track the activities of leading companies
Pharma Technology Focus is our digital magazine, free to read online on all devices. Click the magazine cover to read the latest issue. You can subscribe for free to have each new issue delivered to your inbox.
Patient-centric approaches thrive on wearables and remote access in trials
Pharma’s AI prospects get nudged into the future with EU’s AI act
Are regulators keeping pace with AI adoption in clinical trials?
AI-automated IVF procedures represent a new era in fertility treatment